The Convergence Program of Healthcare & Biomedical Engineering is an interdisciplinary system that combines the principles of engineering and medicine. In academic and technological aspects, biotechnology, medical technology, nano-bio technology, U-health, and diverse fields of science and engineering such as chemical, mechanical, electronic, and computer engineering are combined into new academic fields of medical science and technology. These convergence programs deals with biomateirals, radiological/biological new drugs, drug delivery systems, radiation therapy, micro-fluidics, biosensors, computers, bio-related chemistry, and biomechanics. This program is jointly operated by the two national institutes of Seoul National University of Science and Technology (SeoulTech) and Korea Institute of Radiological and Medical Sciences (KIRAMS). By combining the infrastructure of SeoulTech’s engineering and science oriented system with KIRAMS’s clinical and medical research system, this program will cultivate and re-educate competitive human resources in the areas of healthcare and biomedical technology.
Education and Research Focus Areas
Education of Research Experts in the HT-BT-IT Industry
  • Science and engineering in the areas of healthcare technology, biotechnology, information technology, nanotechnology, and biomedical engineering
  • Intelligent biomaterials: Functional biomaterials, bio/radiological drug delivery systems, diseases diagnostics and treatment devices, and tissue-regeneration engineering
  • Biomedical engineering: Human-supporting devices, nanotechnology, Bio-MEMS/NEMS, surgery robots, medical devices, 3-D bio-printers based on tissue engineering, (stem) cell engineering, bioreactors and micro-fluidics
  • Bio-IT convergence sciences and engineering: Cancers and chronic diseases diagnostics and treatment technology based on U-health technology such as RF technology/bio-nano technology
Jointly Operated Program of SeoulTech-KIRAMS
  • Cooperation of SeoulTech’s divers science and engineering and KIRAMS’s clinicians, accelerators, medical biology, and physics
  • Nano-biotechnology, stem cell engineering, diseases-curing accelerators, radiation/drugs for cancer treatments, prevention of metastasis and minimization of their side effects
  • Regeneration of patient’s tissues and organs based on stem cells, bioactive materials, biomaterials, and new drugs
  • Biomedical-IT engineering, such as data mining, patient-specific diagnostics and treatment technology, and U-health
  • Convergence technologies related to human-supporting devices, U-health, medical devices, bioengineering, digital medical imaging devices, bio/radio-active drugs, and micro-fludics
Applications and Related Industries
  • Biomedical industries related to healthcare, biomaterials, U-health, functional medical devices, medical diagnostics and therapeutics, bio/chemical drugs, and radio-active drugs
  • Radiation and pharmaceutical industries related to cancers and chronic diseases
  • Rehabilitation and human-supporting industries
  • Healthcare-biomedical industry, bioengineering industry, and medical devices and equipment
Department of the Characteristics and Development Prospects
  • Specialization in convergence of healthcare-biomedical engineering by jointly operated system with SeoulTech and KIRAMS
  • (Re)education of bioengineering human resources (in healthcare industries) in the areas of biotechnology, medical engineering, nano-biotechnlogy, healthcare, and medical devices
  • Unique education system in northeastern Seoul related to bio-industries such as radiation-related therapeutics, biomaterials, sports-related healthcare, cell engineering, and devices
  • Global reeducation system related to IAEA